<HashMap><database>iProX</database><scores/><additional><omics_type>Proteomics</omics_type><submitter>Yitao Qi</submitter><species>Mus Musculus</species><full_dataset_link>http://www.iprox.org/page/project.html?id=IPX0017909000</full_dataset_link><submitter_email>qiyitao@snnu.edu.cn</submitter_email><submitter_affiliation>Shaanxi Normal University</submitter_affiliation><sample_protocol></sample_protocol><repository>iProX</repository><data_protocol></data_protocol></additional><is_claimable>false</is_claimable><name>Mechanistic study of SENP2-PCYT1A axis regulating synaptic pruning that results in anxiety-like behavior</name><description>Anxiety disorder, one of the most common mental illnesses, is emerging as a significant public health challenge. Glial regulation of neuronal synaptic pruning offers a novel therapeutic avenue for anxiety; however, it remains unclear whether SUMO modification is involved in this regulatory process. In this study, we demonstrate that both global and microglia-specific SENP2 knockout mice exhibit anxiety-like behaviors coupled with aberrant synaptic pruning, whereas neuronal-specific knockout animals do not show these phenotypes. Moreover, SENP2 specifically modulates LC3-associated phagocytosis (LAP) in microglia and removes SUMO modifications from the target protein PCYT1A. We propose that the SENP2–PCYT1A signaling axis in microglia/astrocyte governs LAP pathway activity, thereby maintaining synaptic pruning homeostasis and preventing the onset of anxiety-like behaviors. Accordingly, this project will (1) define the precise role of LAP in microglial/astrocyte synaptic pruning, (2) elucidate the molecular mechanism by which SUMOylation regulates key factors in the LAP pathway, and (3) investigate how the SENP2–PCYT1A axis modulates synaptic stability and anxiety-related behaviors. These findings not only advance our understanding of SUMO modification in microglia–neuron immune crosstalk but also provide novel insights into potential targeted interventions and precision therapies for anxiety-related mental disorders.</description><dates><publication>Tue Jun 23 00:00:00 BST 2026</publication></dates><accession>PXD080104</accession><cross_references><TAXONOMY>10090</TAXONOMY></cross_references></HashMap>